Tumor boards are “high-stakes, high-cost meetings for high-risk patients,” says Timothy Keyes, a data scientist at Stanford Health Care and a combined MD and PhD candidate in cancer biology and biomedical informatics at Stanford University School of Medicine.
Read the story here: https://news.microsoft.com/source/features/ai/meet-4-developers-leading-the-way-with-ai-agents/